Dr Reddy's Labs gains on relaunch of generic Nexium
The re-launch is due to a change in the capsule colour
 "Dr Reddy’s formulation facility")
Dr Reddy’s formulation facility
Shares of Dr Reddy's Labs were up over 1% at Rs 3,137 on the Bombay Stock Exchange after the company announced the relaunch of its Esomeprazole Magnesium delayed-release capsules in the US market.
The capsules are therapeutic equivalent generic version of Nexium (esomeprazole magnesium) delayed-release capsules of Astrazeneca AB Corporation, the company said in a release.
The re-launch is due to a change in the capsule colour, the release added.
The stock opened at Rs 3,124 and touched a high of Rs 3,171. At 2pm, over 478,000 shares were traded on both the stock exchanges.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 30 2015 | 12:50 PM IST